Durvalumab 120mg/2.4ml solution for infusion vials
- SNOMED code
35875711000001103- Active compound
- Durvalumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 2.4 ml, vial
- Ingredients
- Durvalumab
— 50 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials (AstraZeneca UK Ltd)
in short Imfinzi 120mg/2.4ml concentrate for inf vials
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials
- SNOMED code
35875911000001101- Supplier
- AstraZeneca UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) 1 vial35876011000001109 ref. pack | 💯 Available Legal category: POM | 05000456031240 | NHS Indicative Price £592 | • Hospital |
| — |
Reference packs
Durvalumab 120mg/2.4ml solution for infusion vials 1 vial
- SNOMED code
35875811000001106- Quantity and unit
- 1 vial
- Packs